Biogen (BIIB) Minority Interest (2009 - 2023)

Biogen (BIIB) has reported Minority Interest for 15 consecutive years, with -$4.1 million the latest figure, recorded in Q3 2023.

• In Q3 2023, Minority Interest rose 52.87% year-over-year to -$4.1 million; the TTM figure through Sep 2023 stood at -$4.1 million (up 52.87% YoY), while the FY2022 annual figure was -$9.5 million, down 114.96% from the prior year.
• Minority Interest came in at -$4.1 million for Q3 2023 at Biogen, up from -$6.4 million in the prior quarter.
• The five-year high for Minority Interest was $462.9 million in Q2 2021, with the low at -$21.6 million in Q1 2022.
• Average Minority Interest over 5 years is $42.8 million, with a median of -$8.7 million recorded in 2022.
• Across the five-year window, Minority Interest plunged 375.61% in 2020 and jumped 3327.14% in 2021, its largest moves.
• Year by year, Minority Interest stood at -$4.1 million in 2019, then plunged by 246.34% to -$14.2 million in 2020, then jumped by 547.18% to $63.5 million in 2021, then plunged by 114.96% to -$9.5 million in 2022, then surged by 56.84% to -$4.1 million in 2023.
• According to Business Quant data, Minority Interest over the past three periods registered -$4.1 million, -$6.4 million, and -$9.6 million for Q3 2023, Q2 2023, and Q1 2023 respectively.